ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Non-Invasive – Minimalistic Approach Using Cell-Free MicroRNAs in Paired Plasma and Urine Samples for Early Diagnosis of Chronic Renal Allograft Dysfunction.

    S. Bontha,1 R. Gehrau,1 E. Rhone,1 A. King,2 L. Gallon,3 K. Brayman,1 D. Maluf,1 V. Mas.1

    1Surgery, UVA, Charlottesville, VA; 2VCU, Richmond; 3NWU, Chicago.

    Background: Reducing use of tissue biopsy by efficiently using non-invasive samples for continuous monitoring and evaluation of graft function would be ideal. Reports indicate continuous…
  • 2016 American Transplant Congress

    Living Donor Kidney Transplant Outcomes Have Improved Over the Last Decade.

    A. Nishio Lucar, G. Vranic, D. Keith.

    Medicine, University of Virginia, Charlottesville, VA.

    Our group recently reported improved 6-month eGFR and long-term patient and allograft outcomes in deceased donor transplant over the last decade. Our goal was to…
  • 2016 American Transplant Congress

    Randomized Controlled Study Evaluating Adherence Monitoring with Electronic Feedback on Reducing Renal Allograft Rejection.

    A. Bodzin, Y. Becker, M. Josephson, P. Witkowski, M. Lockwood, L. Potter, B. Kane, L. Lourenco, J. Millis.

    Transplant Center, University of Chicago, Chicago, IL.

    Purpose: The negative impact of non-adherence to the immunosuppressant medication (IM) regimen on transplant outcomes is well recognized. In an attempt to improve outcomes, the…
  • 2016 American Transplant Congress

    Clinical Significance of Isolated v1 Arteritis in Renal Transplantation.

    D. Mikhail,1,3 J. Wei,3 D. Kleinsteuber,2 M. Gabril,2,3 A. Sener,1,3 M. Moussa,2,3 P. Luke.1,3

    1Department of Surgery, Division of Urology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; 2Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; 3Undergraduate Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

    INTRO: The presence of intimal arteritis (v) in renal transplant biopsies (Bx) establishes Grade II-III AVR (Acute Vascular Rejection) according to the Banff Classification. The…
  • 2016 American Transplant Congress

    CD57+ CD4 T Cells Persist in the Periphery Following Kidney Transplantation.

    J. Espinosa,1,2 L. Stempora,1 R. Townsend,3 A. Kirk.1

    1Duke University, Durham; 2Emory University, Atlanta; 3Bristol-Meyers Squibb, Princeton.

    Purpose: We have shown that CD57+PD1- CD4 T cells play a role in belatacept-resistant rejection, but their mechanism of action is incompletely defined. Potential mechanisms…
  • 2016 American Transplant Congress

    Reciprocity for Compatible Pair Participation in Kidney Paired Donation.

    J. Gill,1 M.-C. Fortin,2 C. Rose,1 E. Cole,3 K. Tinckam,3 J. Gill.1

    1Nephrology, UBC, Vancouver, BC, Canada; 2Nephrology, CHUM, Montreal, QC, Canada; 3Nephrology, UHN, Toronto, ON, Canada.

    Participation of ABO and HLA compatible pairs (CPs) in kidney paired donation (KPD) could significantly increase living donor (LD) transplantation (TX). CPs may be more…
  • 2016 American Transplant Congress

    Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea.

    J. An,1,2 S. Ahn,3 E. Bae,2 E. Kang,2 H.-L. Kim,4 Y.-J. Kim,5 Y. Oh,1,2 C. Lim,1,2 Y. Kim,2 Y. Kim,6 J. Lee.1,2

    1Division of Nephrology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 2Division of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; 3Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, Korea; 4Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 5Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; 6Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.

    Background - Pre- or post-transplant cardiovascular (CV) risk factors affect the development of CV events even after successful kidney transplantation (KT). However, the impact of…
  • 2016 American Transplant Congress

    KDPI Outcomes and Discard Rates – The Contradiction of the U.S. and European Approach.

    L. Lehner, A. Kleinsteuber, F. Halleck, D. Khadzhynov, M. Duerr, K. Budde, O. Staeck.

    Dept. of Nephrology CCM, Charite Berlin, Berlin, Germany.

    Introduction: Only a few data exist on the KDPI in European patients (pts). We evaluated the influence of donor factors assessed by the KDPI on…
  • 2016 American Transplant Congress

    Ibrutinib Suppresses Alloantibody Responses in A Mouse Model of Allosensitization: A Preliminary Report.

    G. Wu, I. Kim, N.-N. Chai, A. Klein, S. Jordan.

    CTC/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Ibrutinib is a Bruton tyrosine Kinase (BTK) antagonist that inhibits B cell receptor (BCR) signaling, therefore blocking B cell activation. Ibrutinib is approved by…
  • 2016 American Transplant Congress

    Single Cell Profiling of Th9 Cells Allows Identification of Functionally Different Subsets.

    K. Stanko, J. Schumann, K. Vogt, S. Schlickeiser, C. Appelt, B. Sawitzki.

    Institute of Medical Immunology, Charite University Medicine, Berlin, Germany.

    T helper type 9 (Th9) cells represent a distinct subset of CD4+ effector T cells that is characterized by high secretion of interleukin (IL)-9. Protective…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences